6-O-α-D-Maltosyl-β-cyclodextrin - CAS 104723-60-6
Not Intended for Therapeutic Use. For research use only.
Product Name:
Catalog Number:
CAS Number:
6-O-α-D-Maltosyl-β-cyclodextrin is a cellular cholesterol modifier which can form soluble inclusion complex with cholesterol and is much less cytotoxic to human erythrocytes and Caco-2 cells.
Molecular Weight:
Molecular Formula:
Chemical Structure
CAS 104723-60-6 6-O-α-D-Maltosyl-β-cyclodextrin

Related Products

CAS 58-96-8 Uridine

(CAS: 58-96-8)

Uridine is a nucleoside, contains a uracil attached to a ribose ring via a β-N1-glycosidic bond.

CAS 132836-42-1 YS-49

(CAS: 132836-42-1)

Anti-inflammatory agent; Antithrombotic; Antiplatelet; YS-49 protects cells from oxidant injury; induces heme oxygenase (HO-1) in endothelial cells and protects...

CAS 137071-32-0 Pimecrolimus

(CAS: 137071-32-0)

Pimecrolimus is an immunophilin ligand, which binds specifically to the cytosolic receptor, immunophilin macrophilin-12.

ABT 38396
(CAS: 4853-98-9)

ABT 38396 is a synthetic bio-active chemical.

CAS 5466-77-3 Octinoxate

(CAS: 5466-77-3)

Octinoxate is an organic compound that is an ingredient in some sunscreens and lip balms used in sunscreens and other cosmetics

(CAS: 756500-23-9)

Cyclo(RADfK) is a selective α(v)β(3) integrin ligand. It has been used for research, therapy, and diagnosis of neoangiogenesis. It is also used as a negative co...

CAS 1217022-63-3 PTC-209 hydrobromide

PTC-209 hydrobromide
(CAS: 1217022-63-3)

Polycomb complex protein BMI-1 is a polycomb ring finger oncogene that regulates the p16 and p19 cell cycle inhibitor genes. It is necessary for efficient self-...

CAS 34670-43-4 4-Azido-L-phenylalanine hydrochloride

4-Azido-L-phenylalanine hydrochloride
(CAS: 34670-43-4)

4-Azido-L-phenylalanine is an unnatural derivative of L-phenylalanine, a nonpolar, essential amino acid that naturally occurs in the human body and is also used...

CAS 517-28-2 Hematoxylin

(CAS: 517-28-2)

Hematoxylin (Hydroxybrazilin) is a compound that forms strongly colored complexes with certain metal ions, notably Fe(III) and Al(III) salts and a kind of stain...

CAS 1021-11-0 Guanoxyfen sulfate

Guanoxyfen sulfate
(CAS: 1021-11-0)

Guanoxyfen sulfate is an inhibitor of vasoconstrictor responses to sympathetic nerve stimulation. It could potentiate the actions of adrenaline and noradrenalin...

CAS 443642-29-3 7-Deaza-2'-C-methyladenosine

(CAS: 443642-29-3)

7-Deaza-2’-C-methyladenosine is a hepatitis C virus (HCV) polymerase inhibitor.

CAS 86170-12-9 CGP 23996

CGP 23996
(CAS: 86170-12-9)

CGP 23996 is a non-reducible somatostatin analog. It can be used for autoradiography.

CAS 6055-19-2 Cyclophosphamide Monohydrate

Cyclophosphamide Monohydrate
(CAS: 6055-19-2)

Cyclophosphamide Monohydrate is a nitrogen mustard alkylating agent, it attaches the alkyl group to the guanine base of DNA. It is used to treat cancers and aut...

CAS 34597-40-5 Fenoprofen Calcium

Fenoprofen Calcium
(CAS: 34597-40-5)

Fenoprofen Calcium is a nonsteroidal, anti-inflammatory antiarthritic agent.

(CAS: 400647-59-8)

Doxorubicin-SMCC, a derivative of doxorubicin with a SMCC linker, can react with sulfhydryl groups at pH 6.5-7.5 to form a stable thioether bond. Doxorubicin-SM...

CAS 110140-89-1 Ridogrel

(CAS: 110140-89-1)

Ridogrel is a thromboxane synthase inhibitor used for the prevention of systemic thrombo-embolism. It is also a receptor antagonist that may be used as an adjun...

CAS 39262-14-1 Ginsenoside C-K

Ginsenoside C-K
(CAS: 39262-14-1)

Ginsenoside C-K is an intestinal microbiota metabolite of ginsenoside Rb1, which possesses anti-proliferative and anti-inflammatory activities.

(CAS: 14760-71-5)

MK785, an imidazol derivative, has been found to inhibit the formation of aortic histamine through influencing the aortic histidine decarboxylase at some extent...

CAS 547-44-4 Sulfacarbamide

(CAS: 547-44-4)

Sulfacarbamide is an antibiotic acting on the vegetative nervous system.

CAS 1035979-44-2 P005672 HCl

P005672 HCl
(CAS: 1035979-44-2)

P005672 HCl is a novel, tetracycline-substituted, narrow-spectrum antibiotic compound used for treatment of bacterial infections and neoplasms. It is developed ...

Reference Reading

1.Complex of branched cyclodextrin and lidocaine prolonged the duration of peripheral nerve block.
Suzuki R1, Arai YC, Hamayasu K, Fujita K, Hara K, Yamaguchi T, Sasaguri S. J Anesth. 2009;23(2):295-7. doi: 10.1007/s00540-008-0720-5. Epub 2009 May 15.
Although laboratories have tried to synthesize new local anesthetics, currently available local anesthetics rarely provide prolonged regional blockade. New models of sustained-release preparations of local anesthetics with liposomes and microspheres have been studied to prolong the duration of the effects of the local anesthetics. In the present study, we examined whether a complex of a branched cyclodextrin (CD), 6-O-alpha-D-maltosyl-beta-cyclodextrin (G2-beta-CD) and lidocaine could prolong local nerve block when compared with plain lidocaine. The sciatic nerve in male Sprague-Dawley rats was blocked with plain lidocaine (n = 10), the complex of G2-beta-CD + lidocaine (n = 10), or plain G2-beta-CD (n = 4). Sensory block was assessed with a hotplate set at 56 degrees C. The median duration of the block was longer in the complex group than in the plain lidocaine group (110 min; range, 70-150 min vs 55 min; range, 40-80 min; P < 0.05), thus demonstrating that the complex with CyD significantly prolonged the nerve block effect of lidocaine.
2.Experimental and Theoretical Investigations on the Supermolecular Structure of Isoliquiritigenin and 6-O-α-D-Maltosyl-β-cyclodextrin Inclusion Complex.
Li B1, Liu B2, Li J3, Xiao H4, Wang J5, Liang G6. Int J Mol Sci. 2015 Aug 4;16(8):17999-8017. doi: 10.3390/ijms160817999.
Isoliquiritigenin (ILTG) possesses many pharmacological properties. However, its poor solubility and stability in water hinders its wide applications. The solubility of bioactive compounds can often be enhanced through preparation and delivery of various cyclodextrin (CD) inclusion complexes. The 6-O-α-D-maltosyl-β-CD (G2-β-CD), as one of the newest developments of CDs, has high aqueous solubility and low toxicity, especially stable inclusion characteristics with bioactive compounds. In this work, we for the first time construct and characterize the supermolecular structure of ILTG/G2-β-CD by scanning electron microscopy (SEM), ultraviolet-visible spectroscopy (UV), Fourier transform infrared spectroscopy (FT-IR), and X-ray diffractometry (XRD). The solubility of ILTG in water at 25 °C rises from 0.003 to 0.717 mg/mL by the encapsulation with G2-β-CD. Our experimental observations on the presence of the ILTG/G2-β-CD inclusion complex are further supported by the ONIOM(our Own N-layer Integrated Orbital molecular Mechanics)-based QM/MM (Quantum Mechanics/Molecular Mechanics) calculations, typically substantiating these supermolecular characteristics, such as detailed structural assignments, preferred binding orientations, selectivity, solvent effects, interaction energies and forces of the ILTG/G2-β-CD inclusion complex.